SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has rallied to a fresh 52-week high as traders position ahead of the Q3 report, focusing on BRIUMVIs sales growth and possible guidance changes. The move has also fueled unconfirmed Sanofi buyout and short-squeeze speculation, while some traders caution that the rally may have priced in strong results.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Berkshire Hathaways large disclosed stake in Lennar has drawn attention, with bulls viewing the buying as a vote of confidence while others question whether it signals a bottom. The bullish case is offset by weak results and a lowered delivery outlook amid high mortgage rates, plus Hunterbrooks allegations about Lennars transactions with its Millrose spinoff, which have raised concerns among traders.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

A Northland upgrade citing C3 Code as a potential growth driver for agentic AI has renewed interest in C3.ai, alongside unusual call-option activity and short-squeeze speculation. Traders are divided between optimism about the product and enterprise AI demand, and concern over declining revenue and continued losses.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave shares are drawing attention amid a steep selloff across quantum-computing stocks, with traders questioning whether high valuations, limited near-term commercialization and competition from classical AI can support the sector ahead of Q3 results. Some see the pullback as a buying opportunity, while others expect more downside.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in London, Canada.

Aduro Clean Technologies Inc

Aduros reported pilot results showing high condensable-hydrocarbon yields across polypropylene and mixed polyolefin feeds are driving discussion, alongside progress toward its planned first-of-a-kind facility. Bulls see the results and engineering work as validation of its plastics-recycling technology, while skeptics argue that yields do not establish commercial economics or scalability.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

Discussion centers on REalloys potential role in a North American rare-earth and magnet supply chain, with traders pointing to U.S. defense sourcing restrictions taking effect in 2027 and the companys Army-linked Tooele project and Tanbreez offtake as longer-term catalysts. Bulls see strategic demand upside, while bears focus on the lack of recent operational updates, execution and dilution risks, and sharp volatility.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is seeing significant momentum as traders react to a major five-year storage agreement with CoreWeave, fueling intense speculation about the company's role in the AI infrastructure supply chain. The community is actively debating the stock's potential for further upside against concerns regarding capital needs and the possibility of future share offerings.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms sharp decline is being discussed mainly as part of a broad semiconductor selloff following Intels weak outlook, with traders also noting bearish put-heavy options activity. The community is split between treating the drop as a buying opportunity and worrying about further downside ahead of Qualcomms earnings report.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

Concerns that heavy AI infrastructure spending is weighing on cash flow and may not deliver adequate returns are fueling debate around the Magnificent Seven basket as MAGS pulls back. Bears see the spending and valuation risks as a broader AI-trade warning, while bulls view the weakness as a correction or rotation and point to support in the mega-cap names.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Ionis and AstraZenecas Wainua Phase 3 ATTR-CM trial missed its primary endpoint, drawing attention to potential competitive read-through for Alnylams TTR franchise and upcoming cardiomyopathy pipeline. Traders are divided: some view the failure as removing a rival and strengthening Amvuttras position, while others see it as raising broader questions about TTR silencers and increasing risk around Alnylams development plans.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TriMas (TRS) Q3 Earnings Match Estimates

TriMas (TRS) delivered earnings and revenue surprises of 0.00% and +1.96%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

TriMas Reports Third Quarter 2026 Results

TriMas (NASDAQ: TRS) today announced financial results for the third quarter ended September 30, 2026. TriMas reported third quarter 2026 net sales of $178.7 million, an increase of 7.7% compared to $166.0 million in third quarter 2025, driven by organic growth within TriMas Packaging and Specialty...

NN Inc. (NNBR) Q3 Earnings and Revenues Surpass Estimates

NN (NNBR) delivered earnings and revenue surprises of +250.00% and +12.05%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Trimas Declares Quarterly Dividend

TriMas (NASDAQ: TRS) announced today that its Board of Directors declared a quarterly cash dividend of $0.04 per share of TriMas Corporation stock. The quarterly dividend is payable on November 12, 2026, to shareholders of record as of the close of business on November 5, 2026. About TriMas TriMas...

TriMas Announces Third Quarter 2026 Earnings Conference Call Date

TriMas (NASDAQ: TRS) today announced that it will hold its third quarter 2026 earnings conference call on Thursday, October 29, 2026, at 10 a.m. Eastern Time. The call will follow the Companys release of its earnings results earlier that morning at 8:00 a.m. Eastern Time. Earnings Call Access: U.S...

TriMas Packaging to Showcase Global Beauty Packaging Capabilities at Leading Trade Shows This Fall

TriMas Packaging, part of TriMas (NASDAQ: TRS), will showcase its global portfolio of dispensing, closure and customized packaging solutions for the fragrance, beauty and personal care markets at two of the industry's premier events this fall, LUXE PACK Monaco and Beautyworld Dubai.LUXE PACK...

TriMas Publishes 2025 Sustainability Report

TriMas (NASDAQ: TRS) today announced the release of its 2025 Sustainability Report, highlighting meaningful progress across the Company's environmental, social and governance (ESG) priorities. During 2025, TriMas surpassed its 2030 greenhouse gas emissions and water withdrawal intensity reduction...

TriMas (TRS) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

TriMas Corporation Q2 2026 Earnings Call Summary

TriMas Corporation Q2 2026 Earnings Call Summary...

TriMas (TRS) Q2 Earnings Top Estimates

TriMas (TRS) delivered earnings and revenue surprises of +6.12% and -1.89%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

$TRS Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.50 up 194.12% YoY
• Reported revenue of $178.74M down -33.62% YoY
• TriMas reaffirmed full-year 2026 adjusted diluted EPS outlook of $1.60 to $1.70, expects sales growth of 4% to 6%, and approximately 250 basis points of adjusted operating profit margin expansion.

Stocktwits

Trimas Corporation

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.50 up 194.12% YoY
• Reported revenue of $178.74M down -33.62% YoY
• TriMas reaffirmed full-year 2026 adjusted diluted EPS outlook of $1.60 to $1.70, expects sales growth of 4% to 6%, and approximately 250 basis points of adjusted operating profit margin expansion.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of $0.50 up 194.12% YoY
• Reported revenue of $178.74M down -33.62% YoY
• TriMas reaffirmed full-year 2026 adjusted diluted EPS outlook of $1.60 to $1.70, expects sales growth of 4% to 6%, and approximately 250 basis points of adjusted operating profit margin expansion.

TriMas reported Specialty Products' lower operating profit amid raw-material recovery lag and manufacturing inefficiencies, Norris Cylinder throughput challenges, and net cash used in continuing operating activities in Q3 2026.

TriMas Packaging sales and adjusted operating profit and margin improved; Rapak's planned sale advances portfolio optimization, and cash and available borrowing capacity totaled $1.37B.

TriMas Corp. engages in the manufacture of industrial products for customers in the consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets. It operates through the following segments: Packaging and Specialty Products. The Packaging segment develops and manufactures dispensing products, polymeric and steel caps and closures, polymeric jar products, and fully integrated dispensers for fill-ready bag-in-box applications, beauty and personal care, home care, food and beverage, and pharmaceutical and nutraceutical products. The Specialty Products segment focuses on designing, manufacturing, and distribution of highly-engineered steel cylinders for use within industrial and aerospace markets. The company was founded by Brian P. Campbell in 1986 and is headquartered in Bloomfield Hills, MI.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$38.14
Prev Close	$38.68
Open	$38.52
Dividend Yield	0.45%
50-Day Moving Average	$38.95
Beta	0.82
Avg. Volume	310,729.03
PE Ratio	1.57

52-Week High	$45.43
52-Week Low	$30.43
Market Capitalization	$1.37B
EPS (Annual)	$2.95
Price to Book	0.95
Revenue Per Employee	$174,518.92

Feed

News

Sentiment

Earnings

Fundamentals

Info

TRS Fundamentals